![](https://dbtnews.com/wp-content/uploads/2020/01/Image-74.png)
Recursion Pharmaceuticals Inc [RXRX] Revenue clocked in at $49.63 million, down -38.44% YTD: What’s Next?
Recursion Pharmaceuticals Inc [NASDAQ: RXRX] loss -16.62% on the last trading session, reaching $6.07 price per share at the time. If compared to the average trading volume of 5.56M shares, RXRX reached a trading volume of 13341654 in the most recent trading day, which is